Filed before 2025Filed 9 November 2016
Metacrine, Inc. has sold $37.8M so far
Metacrine, Inc., a pharmaceuticals company based in San Diego, CA, has sold $37.8M so far in its equity round, according to a filing dated 9 November 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 November 2016
- First filed
- 13 April 2015
- Round
- Equity round (amended filing)
- Amount sold
- $37.8M
- Offering size
- $37.8M
- Investors so far
- 20
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 93% of the 1,506 tracked raises with an amount filed in 2016, and than 84% of the 50 in pharmaceuticals.
Metacrine, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Jun 2018 | New filing | $65M | Another raise |
| 13 Dec 2017 | New filing | $22M | Another raise |
| 9 Nov 2016 | Amended filing | $37.8M | This raise |
| 6 Oct 2015 | Amended filing | $12.1M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.